INS Protein-Regulating microRNA Panel in Gene Reversal Strategies for Type 2 Diabetes Mellitus

Abstract

Background: Type 2 Diabetes Mellitus remains a major global health issue in both developed and developing nations. In Diabetes the body loses its ability to respond properly to insulin. As much research has focused on how the INS gene is controlled at the transcription level. But still less attention has been given to what happens afterward. In particular, small molecules known as miRNAs play a quiet and powerful role in regulating insulin production. These tiny RNA molecules bind to messenger RNAs and block them.

Objective: To pinpoint particular microRNAs that influence insulin production post-transcription. In order to investigate if targeting these miRNAs might aid in restoring insulin levels.

Methods: A case-control study involved 40 participants. Possible miRNAs were initially discovered utilizing computational resources like TargetScan 8.0, miRDB, and other. The levels of their expression were subsequently assessed using quantitative real-time PCR. Insulin levels in serum were evaluated using ELISA. Correlation analysis was conducted.

Results: Hence, seven miRNAs were displaying notable variations between diabetic and healthy people. In T2DM patients, five miRNAs (miR-375, miR-7, miR-29a, miR-29b, and miR-21) showed a significant increase. Whereas two (miR-30d and miR-146a) exhibited a decrease.

Conclusion: Overall, the results indicate that network of microRNAs collaborates to decrease insulin production in T2DM. By inhibiting detrimental miRNAs or reinstating helpful ones, it might be feasible to reactivate insulin secretion. These strategies may signify a novel pathway for gene-focused treatments in diabetes care.